This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

CVS Caremark's Chief Medical Officer Troyen Brennan Is Named To The National Commission On Physician Payment Reform









WOONSOCKET, R.I., March 5, 2012 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced that Troyen A. Brennan, MD, MPH, executive vice president and chief medical officer of the company, has been named to the National Commission on Physician Payment Reform, an independent commission that will assess how physicians are paid, and how pay incentives are linked to patient care.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)  

The commission is sponsored by the Society of General Internal Medicine. The new panel is comprised of physicians, representatives from health care, insurance, a state health department, as well as health policy leaders and a consumer representative. Commission members will offer a range of perspectives in their efforts to provide a roadmap of cost-conscious payment changes that will help rein in health care spending while at the same time optimizing patient care.

The Commission will meet over the course of one year and issue recommendations in early 2013. The Commission is funded in part by the Robert Wood Johnson Foundation, the California Healthcare Foundation, and the Sergei Zlinkoff Fund for Medical Education and Research.

Before joining CVS Caremark in 2008, Brennan served as chief medical officer for Aetna Inc and president and CEO of Brigham and Women's Physicians Organization in Boston, MA. He is a member of the Institute of Medicine of the National Academy of Sciences. He has his MD and MPH from Yale Medical School, a JD from Yale Law School, a MA from Oxford University and a BS from Southern Methodist University, Texas. He has served on the faculties of Harvard Medical School, Harvard Law School and the Harvard School of Public Health.



About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are a pharmacy innovation company, uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com.

Media Contact: Jon Sandberg CVS Caremark (401)770 4914 jon.sandberg@cvscaremark.com



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs